Cost-effectiveness of different diagnostic strategies to assess gastro-oesophageal reflux disease in patients with unexplained chronic persistent cough in Italy

Digestive and Liver Disease

Volumn 38, Issue 7, 2006, Pages 452-458

  Baldi, F ^a   Cavoli, C ^a   Ghersi, S ^a   Mantovani, L ^b   Torresan, F ^a   Roda, E ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

24 h oesophageal pH metry; Chronic cough; Cost effectiveness; GORD; PPI test

Indexed keywords

LANSOPRAZOLE;

ABSENTEEISM; ADULT; AGED; ARTICLE; CHRONIC DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST CONTROL; COST EFFECTIVENESS ANALYSIS; COUGHING; DECISION THEORY; DIAGNOSTIC PROCEDURE; ESOPHAGOGASTRODUODENOSCOPY; ESOPHAGUS PH; FEMALE; GASTROESOPHAGEAL REFLUX; HEALTH CARE COST; HEALTH ECONOMICS; HUMAN; INTERMETHOD COMPARISON; ITALY; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PH MEASUREMENT; PROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY;

CHRONIC DISEASE; COST-BENEFIT ANALYSIS; COUGH; FEMALE; GASTROESOPHAGEAL REFLUX; HUMANS; ITALY; MALE; MIDDLE AGED; SENSITIVITY AND SPECIFICITY;

EID: 33748504765     PISSN: 15908658     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.dld.2006.02.015     Document Type: Article

References (32)

1. Richter J.E. Extraesophageal presentations of gastroesophageal reflux disease: an overview. Am J Gastroenterol 95 Suppl. (2000) S1-S3
2. Lrwin R.S., and Richter J.E. Gastroesophageal reflux and chronic cough. Am J Gastroenterol 95 (2000) S9-S14
3. Irwin R.S., Curley F.J., and French C.L. Chronic cough: the spectrum and frequency of causes, key components of the diagnostic evaluation, and outcome of specific therapy. Am Rev Respir Dis 141 (1990) 640-647
4. Richter J.E. Ear, nose and throat and respiratory manifestations of gastro-esophageal reflux disease: an increasing conundrum. Eur J Gastroenterol Hepatol 16 (2004) 837-845
5. Fass R., Fennerty M.B., Ofman J.J., Gralnek I.M., Johnson C., Camarge E., et al. The clinical and economic value of a short course of omeprazole in patients with noncardiac chest pain. Gastroenterology 115 (1998) 42-49
6. Schenk B.E., Kuipers E.J., Klinkenberg-Knol E.C., Festen H.P., Jansen E.H., Tuynman H.A., et al. Omeprazole as a diagnostic tool in gastroesophageal reflux disease. Am J Gastroenterol 92 (1997) 1997-2000
7. Fass R., Ofinan J.J., Gralnek I.M., Johnson C., Camarge E., Sampliner R.E., et al. Clinical and economic assessment of the omeprazole test in patients with symptoms suggestive of gastroesophageal reflux disease. Arch Intern Med 159 (1999) 2161-2168
8. Fass R., Ofman J.J., Sampliner R.E., Camango E., Wendel C., and Fennerty M.B. The omeprazole test is as sensitive as 24-h oesophageal pH monitoring in diagnosing gastro-oesophageal reflux disease in symptomatic patients with erosive oesophagitis. Aliment Pharmacol Ther 14 (2000) 389-396
9. Juul-Hansen P., Rydning A., Jacobsen C.D., and Hansen T. High-dose proton-pump inhibitors as a diagnostic test of gastro-oesophageal reflux disease in endoscopic-negative patients. Scand J Gastroenterol 36 (2001) 806-810
10. Johnson F., Hatlebakk J.G., Klintenberg A.C., Roman J., Toth E., Stubberod A., et al. One-week esomeprazole treatment: an effective confirmatory test in patients with suspected gastro-esophageal reflux disease. Scand J Gastroenterol 38 (2003) 354-359
11. Juul-Hansen P., and Rydning A. Endoscopy-negative reflux disease: what is the value of a proton-pump inhibitor test in everyday clinical practice?. Scand J Gastroenterol 38 (2003) 1200-1203
12. Jaspersen D., Diehl K.L., Geyer P., and Martens E. Omeprazole test for gastroesophageal reflux-related chronic persistent cough. Gastroenterology 1 (1999) GO861
13. Fass R. Empirical trials in treatment of gastroesophageal reflux disease. Dig Dis 18 (2000) 20-26
14. Ours T.M., Kavuru M.S., Schilz R.J., and Richter J.E. A prospective evaluation of esophageal testing and a double-blind, randomized study of omeprazole in a diagnostic and therapeutic algorithm for chronic cough. Am J Gastroenterol 94 (1999) 3131-3138
15. Metz D., Childs M.L., Ruiz C., and Weinstein G.S. Pilot study of the oral omeprazole test for reflux laryngitis. Otolaryngol Head Neck Surg 116 (1997) 41-46
16. Ofman J.J., Gralnek I.M., Udani J., Fennerty M.B., and Fass R. The cost-effectiveness of omeprazole test in patients with noncardiac chest pain. Am J Med 107 (1999) 219-227
17. O'Connor J.F.B., Singer M.E., and Richter J.E. The cost-effectiveness of strategies to assess gastroesophageal reflux as an exacerbating factor in asthma. Am J Gastroenterol 4 (1999) 1472-1480
18. Drummond M.F., O'Brien B.J., Stoddart G.L., and Torrance G.W. Methods for the economic evaluation of health care programmes. 2nd ed. (1997), Oxford University Press, Oxford
19. Ollyo J.B. Savary's new endoscopic grading of reflux oesophagitis: a simple, reproducible, logical, complete and useful classification. Gastroenterology 89 (1990) A100
20. Baldi F., Ferrarini F., and Longanesi A. Ambulatory 24-h oesophageal pH monitoring in normal subjects: a multicentre study in Italy. Ital J Gastroenterol 23 (1991) 477-480
21. Nyren O., Adami H.O., Bates S., Bergstrom R., Gustavsson S., Loof L., et al. Self-rating of pain in nonulcer dyspepsia. A methodological study comparing a new fixed-point scale and the visual analogue scale. J Clin Gastroenterol 9 (1987) 408-414
22. Baldi F., Cappiello R., Cavoli C., Ghersi S., Torresan F., and Roda E. Proton pump inhibitor treatment of patients with gastroesophageal reflux-related chronic cough: a comparison between two different daily doses of lansoprazole. World J Gastroenterol 12 (2006) 83-89
23. Weinstein M.C., and Fineberg H.V. Clinical decision analysis (1980), W.B. Saunders, Philadelphia, PA
24. Weinstein M.C., Siegel J.E., Garber A.M., Lipscomb J., Luce Br., Manning Jr. W.G., et al. Productivity costs, time costs and health-related quality of life: a response to the Erasmus Group. Health Economics 6 (1997) 505-510
25. ISTAT. Italian statistical yearbook, 2002 (2002), ISTAT, Rome
26. El Serag H.B., Lee P., Buchner A., Inadomi J.M., Gavin M., and McCarthy D.M. Lansoprazole treatment of patients with chronic idiopathic laryngitis: a placebo-controlled trial. Am J Gastroenterol 96 (2001) 979-983
27. Richter J.E., and Hicks D.M. Unresolved issues in gastroesophageal reflux-related ear, nose and throat problems. Am J Gastroenterol 92 (1997) 43-44
28. Jamieson J.R., Stein H.J., De Meester T.R., Bonavina L., Schwizer W., Hinder R.A., et al. Ambulatory 24-h esophageal pH monitoring: normal values, optimal thresholds, specificity, sensitivity, and reproducibility. Am J Gastroenterol 87 (1992) 1102-1111
29. Koufman J.A. The otolaryngologic manifestations of gastro-esophageal reflux disease (GERD): a clinical investigation of 225 patients using ambulatory 24-hour pH monitoring and an experimental investigation of the role of acid and pepsin in the development of laryngeal injury. Laryngoscope 101 (1991) 1-78
30. Wahlqvist P., Carlsson J., Stalhammar N.O., and Wiklund I. Validity of a work productivity and activity impairment questionnaire for patients with symptoms of gastro-esophageal reflux disease (WPAI-GERD): results from a cross-sectional study. Value Health 5 (2002) 2106-2113
31. Soni S. GI disease presents a monumental economic burden. Pharmacoecon Outcome News 325 (2001) 3-4
32. Ofman J.J., Dorn G.H., Fennerty M.B., and Fass R. The clinical and economic impact of competing management strategies for gastro-oesophageal reflux disease. Aliment Pharmacol Ther 16 (2002) 261-273